Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Sells $113,670.45 in Stock

Share on StockTwits

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Lonnie Smith sold 205 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $554.49, for a total value of $113,670.45. Following the completion of the transaction, the director now owns 368,952 shares of the company’s stock, valued at $204,580,194.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

NASDAQ:ISRG traded down $2.22 during mid-day trading on Tuesday, hitting $579.28. 2,006 shares of the stock were exchanged, compared to its average volume of 535,936. The stock has a market capitalization of $65.82 billion, a price-to-earnings ratio of 61.28, a price-to-earnings-growth ratio of 4.27 and a beta of 1.12. The firm’s 50-day simple moving average is $550.63 and its 200 day simple moving average is $520.57. Intuitive Surgical, Inc. has a fifty-two week low of $430.24 and a fifty-two week high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.99 by $0.44. The business had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. The firm’s revenue for the quarter was up 22.5% compared to the same quarter last year. During the same period last year, the firm posted $2.83 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 10.96 EPS for the current fiscal year.

A number of research firms have weighed in on ISRG. Piper Jaffray Companies set a $633.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research note on Friday, October 18th. UBS Group raised their price objective on Intuitive Surgical from $560.00 to $590.00 and gave the company a “neutral” rating in a research report on Friday, October 18th. ValuEngine raised Intuitive Surgical from a “strong sell” rating to a “sell” rating in a research report on Friday, November 8th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $601.00 price objective for the company in a research report on Thursday, November 21st. Finally, BidaskClub cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Wednesday, September 11th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $587.62.

Large investors have recently added to or reduced their stakes in the stock. Manchester Financial Inc. acquired a new stake in Intuitive Surgical during the 2nd quarter worth approximately $25,000. Golden State Wealth Management LLC acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $35,000. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its holdings in Intuitive Surgical by 733.3% during the 2nd quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 66 shares during the last quarter. FNY Investment Advisers LLC acquired a new stake in Intuitive Surgical during the 2nd quarter worth approximately $47,000. Finally, North Star Investment Management Corp. acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $49,000. 85.59% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Recommended Story: The Structure of a Futures Contract

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Goldstrike Resources  Trading Up 50%
Goldstrike Resources Trading Up 50%
Polypipe Group  Reaches New 1-Year High at $522.50
Polypipe Group Reaches New 1-Year High at $522.50
Tullow Oil  Hits New 12-Month Low at $66.16
Tullow Oil Hits New 12-Month Low at $66.16
Babcock International Group  Hits New 12-Month High at $605.60
Babcock International Group Hits New 12-Month High at $605.60
Macarthur Minerals  Stock Price Up 52.9%
Macarthur Minerals Stock Price Up 52.9%
Canadian Western Bank Forecasted to Post Q1 2020 Earnings of $0.82 Per Share
Canadian Western Bank Forecasted to Post Q1 2020 Earnings of $0.82 Per Share


© 2006-2019 Ticker Report